Impella ®

Circulatory Support System

Percutaneous
 Impella LP2.5 ®

The Impella® LP2.5 is a minimally invasive percutaneous

ventricular unloading catheter that allows the heart to
9F Shaft diameter/
Pump motor diameter
rest and recover by: 12F
• Actively unloading the ventricle
®

• Reducing myocardial workload and oxygen Flow rate up to 2.5 L/min

2.5 L
Impella

consumption, while increasing cardiac output,

coronary- and end-organ perfusion

Quick and easy percutaneous insertion allows rapid

positioning into the left ventricle. Thereafter, up to 2.5 liters
of blood per minute are pumped from the left ventricle into
5 DAYS Up to 5 days support

the ascending aorta – actively unloading the heart for up to

5 days.

The Impella® LP2.5 has been used in European LV Left ventricular support
centers to support patients during high-risk PCI,
post PCI, AMI with low cardiac output.

Inlet area

Inlet area
9F 12F pump motor Outlet area

Actual size

Outlet area

How it works
The Impella® LP catheters (LP – Left
Peripheral) are placed over a guide wire
via the femoral artery in the body. The
catheter is advanced into the left
ventricle, the guide wire is removed, and
the catheter actively unloads the heart
(up to 5 liters of blood per minute). This
facilitates myocardial recovery by
reducing the heart’s workload
simultaneously providing perfusion to
the body organs.

The Impella® 2.5 is an Investigational Device limited by U.S. Federal Law solely for Investigational Use in the United States.
 Impella LP5.0 ®

The Impella® LP5.0 is a minimally invasive ventricular unloading

catheter that provides enhanced hemodynamic support of up to 5.0
9F Shaft diameter/
Pump motor diameter
liters of blood per minute. It allows the heart to rest and recover by: 21F
• Actively unloading the ventricle
• Reducing myocardial workload and oxygen consumption, while Flow rate up to 5 L/min
increasing cardiac output, coronary and end-organ perfusion 5L
Once in place, up to 5 liters of blood per minute is pumped from the left
ventricle into the ascending aorta – actively unloading the heart for up
to 10 days. 10 DAYS Up to 10 days support

The Impella® LP5.0 has been used in European centers to support

patients with postcardiotomy “failure to wean,” post PCI, myocarditis,
AMI cardiogenic shock or as a “Bridge to Next Decision.”
LV Left ventricular support
Inlet area

Inlet area

Outlet area 21F pump motor

Actual size

Outlet area 9F

Impella Mobile Console ®

The Impella® Mobile Console powers Portable,

and controls operational functions for 3 kg weighing only
ALL devices. 3 kg (7 lbs.)

The Console is portable and light-

weight, facilitating easy transport of
BATTERY Battery operating
the patient. time at least 1 hour

The use of push-button technology and

built-in safety alarms facilitates easy
staff training and patient management. POWER Power provided via
the power supply

The Impella® 5.0 is an Investigational Device limited by U.S. Federal Law solely for Investigational Use in the United States.
 Abiomed, Inc. Abiomed Europe GmbH
22 Cherry Hill Drive Neuenhofer Weg 3
Danvers, Massachusetts 01923 USA 52074 Aachen, Germany
Voice: 978-777-5410 Voice: +49 (241) 8860-0
Facsimile: 978-777-8411 Facsimile: +49 (241) 8860-111
Email: marketing@abiomed.com Email: europe@abiomed.com

Impella® Not for Sale in the United States

ABIOMED is a trademark of Abiomed, Inc., and is registered in the U.S.A. and certain foreign countries. The ABIOMED logo and Recovering hearts. Saving lives. are trademarks of Abiomed, Inc. IMPELLA is US
a trademark of Abiomed Europe GmbH, a subsidiary of Abiomed, Inc., and are registered in the U.S.A. and certain foreign countries.
©2006 ABIOMED, Inc. All rights reserved. HCS-014-06